The scholar awards for 2022 'will support a diverse set of drug discovery projects including new treatments for pulmonary diseases, COVID-19, multiple cancers, corneal disease, hepatitis, and acquired spinal cord injuries,' according to Harrington, which is part of University Hospitals.